ArticleCirculation. Cardiovascular quality and outcomes2020

Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015.

Kari R Gillmeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.